RANDOMIZED EVALUATION ON THE CONSUMPTION OF
ANTIBIOTICS IN COMMUNITY PHARMACIES
CORINA MOISA 1#*, ANDREEA MARGARETA VLAD 1#, ALIN TEUȘDEA 2#, OANA CADAR 3#, MARIA ALEXANDRA HOAGHIA 3#, ROXANA LIANA STAN 4#, ADRIANA TĂEREL 5#, CLAUDIA JURCA 1#, LAURA GRAȚIELA VICAȘ 1#
1University of Oradea, Medicine and Pharmacy Faculty, Oradea, Romania
2University of Oradea, Faculty of Environmental Protection, Oradea, Romania
3INCDO-INOE 2000, Research Institute for Analytical Instrumentation, Cluj-Napoca, Romania
4“Iuliu Hațieganu” University of Medicine and Pharmacy, Faculty of Pharmacy, Cluj-Napoca, Romania
5“Carol Davila” University of Medicine and Pharmacy, Faculty of Pharmacy, Bucharest, Romania
*corresponding author: corinamoisa@hotmail.com
#Authors with equal contribution
DownloadDownload Full Article

Abstract:
According to the statistics, each year 400,000 Europeans develop infections with antibiotic-resistant bacterial strain, and
25,000 die due to the exhaustion of all therapeutic resources. These statistics are alarming, considering that medical services
have become lately more and more accessible, but the “antibiotics era”, namely the prescribing of these pharmacological
agents on a large scale, generated the present situation. There is a category of patients who seek specialist medical services,
yet many of them also make errors when it comes to the correct administration of the antibiotics prescribed. The emergence
of antibiotic resistant strains occurred due to the of insufficient or excessive treatment schemes, insufficient doses or
treatment duration. Physicians and pharmacists have an important role in limiting the occurrence and development of the
antibiotics resistant strains. The objective of the present study was the comparative assessment of antibiotic’s consumption in
urban and rural areas, in a western region of Romania for both children and adults, the medicines being prescribed by
physicians and monitored through community pharmacies. The study was conducted over 2 years and involved five types of
active substances, namely amoxicillin, cefuroxime, clarithromycin, sulphametoxazole + trimethoprim and cefixime.






Top